CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Sciton SkinTyte (800-1800 nm) with Broadband Light Technologydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03243981
NCT03243981N/ACompleted
CompareCT.gov

Augmentation of Skin Aging Reversal By Broadband Light With Skin Tightening Properties Via Gene Expression Analysis

Stanford University·interventional·Posted Aug 9, 2017·Updated Oct 1, 2019

In Brief

A clinical study evaluating Sciton SkinTyte (800-1800 nm) with Broadband Light Technology for Aging. Completed, enrolled 5 participants across 1 site.

Detailed Summary

In this exploratory study, we hope to learn if treatment of broadband light with infrared light can alter the molecular pathways associated with aging. Secondary exploratory objective is to see if there are any visible effects of this light treatment on human skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
CollaboratorsSciton

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 9, 2017
Enrollment StartNov 20, 2016
Primary CompletionJun 20, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.9 years ago

Interventions

Sciton SkinTyte (800-1800 nm) with Broadband Light Technologydevice

This device has been used in the clinical setting to reduce cheek and submental laxity. SkinTyte delivers sequentially pulsed light (800-1200 nm, with a filter enabling focus on 590 nm) and broadband light (which can be turned on or off).